You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

  • Technology appraisal guidance
  • Reference number: TA209
  • Published:  24 November 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): commentator comments

  • Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Department of Health response

  • Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): NHS Quality Improvement Scotland response

  • Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Pfizer response

  • Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Welsh Assembly Government response


This page was last updated: 13 September 2010

Back to top